IRRAS Wins Regulatory Approval of IRRAflow® in Israel and Costa Rica

June 25, 2019   |   June 2019 Bond Updates
STOCKHOLM, June 25, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced today that it received regulatory approval for its flagship product, ...

View more at:
Related News
Home| About us | Contact us